WWM
AMPE

Western Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Western Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,224
Closed -$5.7K – 680
2023
Q2 		$5.7K Hold
1,224
– – ﹤0.01% 645
2023
Q1 		$5.7K Sell
1,224
-19
-2% -$107 ﹤0.01% 641
2022
Q4 		$5.6K Buy
1,243
+66
+6% +$426 ﹤0.01% 608
2022
Q3 		$11K Sell
1,177
-706
-37% -$24.7K ﹤0.01% 807
2022
Q2 		$103K Sell
1,883
-1,273
-40% -$94.7K 0.01% 763
2022
Q1 		$444K Buy
+3,156
New +$461K 0.02% 563
2021
Q2 		$1.69M Buy
3,378
+31
+0.9% +$16.6K 0.17% 135
2021
Q1 		$1.7M Buy
3,347
+72
+2% +$37.1K 0.23% 100
2020
Q4 		$1.56M Buy
3,275
+30
+0.9% +$9.84K 0.23% 106
2020
Q3 		$932K Buy
3,245
+418
+15% +$104K 0.15% 155
2020
Q2 		$559K Buy
2,827
+269
+11% +$44.7K 0.1% 206
2020
Q1 		$316K Buy
+2,558
New +$463K 0.07% 259
2019
Q4 		– Sell
-1,751
Closed -$263K – 430
2019
Q3 		$263K Buy
+1,751
New +$233K 0.05% 320

Other funds holding AMPE

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return

Western Wealth Management's AMPE Position: Q3 2023 in Review

Western Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 1,224 shares — an estimated $5.7K sold.

Western Wealth Management first reported a position in AMPE in Q3 2019 and held it in 13 quarters. The position peaked at $1.7M in Q1 2021. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Western Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Western Wealth Management sold 1,224 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $5.7K.
  • Western Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2019 and held it in 13 quarters.
  • Western Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $1.7M in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Western Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.